All News

Should Younger Patients Ever Have Knee Replacement Surgery?

By Christin Melton The Treatment of Choice for Younger Patients Jack M. Bert, MD, an orthopedic surgeon at Minnesota Bone & Joint Specialists in Woodbury, Minnesota, has an important message for his colleagues: Always choose a high tibial osteotomy (HTO)

UI orthopedics researchers working on injectable, bioactive gel that can repair cartilage damage

Knee injuries are the bane of athletes everywhere, from professionals and college stars to weekend warriors. Current surgical options for repairing damaged cartilage caused by knee injuries are costly, can have complications, and often are not very eff…

CyMedica Orthopedics Launches The QB1 System – A Proprietary Device For Treatment Of Quadriceps Atrophy – At AANA

SCOTTSDALE, Ariz., April 29, 2015 /PRNewswire/ — Scottsdale-based CyMedica Orthopedics™, Inc. announced the commercial launch of the CyMedica QB1™ System for the treatment of quadriceps muscle atrophy at the Arthroscopy Association of North American Arthroscopic Society for Sports Medicine (AANA) annual meeting in Los

NuVasive® Reaches Agreement in Principle to Settle OIG Matter

SAN DIEGO, CA–(Marketwired – April 29, 2015) – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that it has reached an agreement

UPDATE – K2M Group Holdings, Inc. to Release First Quarter 2015 Financial Results on May 6th

LEESBURG, Va., April 28, 2015 (GLOBE NEWSWIRE) — In a release issued on Thursday, April 23rd, 2015 by K2M Group Holdings, Inc. (Nasdaq:KTWO) (the “Company”), the Company announced that Management will host a conference call May 6th to discuss the

Analysts Set CONMED Target Price at $53.60 (NASDAQ:CNMD)

By Jim Brewer CONMED (NASDAQ:CNMD) has received a consensus recommendation of “Hold” from the seven brokerages that are presently covering the stock, StockRatingsNetwork reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have assigned

Objective, subjective data similar between patients with, without peripheral nondegenerative MMTs

By Casey Tingle LOS ANGELES — No differences were found in objective and subjective results between patients with peripheral nondegenerative medial meniscus tears treated with trephination alone and a control group without meniscus tears, according to results presented at the

Older patients experience worse outcomes following hip arthroscopy for FAI

By Casey Tingle LOS ANGELES — Following hip arthroscopy for femoroacetabular impingement, patients older than 45 years of age had worse outcomes compared with younger patients, according to a presenter here. “A matched cohort of patients undergoing hip arthroscopy for

Congress Should Hold Oversight Hearings to Ensure FDA Prioritizes Safety for Biosimilars | Commentary

By James Weisman The Food and Drug Administration recently approved the first in a new category of biologic drugs known as “biosimilars,” and soon will consider approval of others. Although biosimilars have great potential for improving patient access to life-saving

Aurora Spine Corporation : FIRST U.S. AND INTERNATIONAL SURGICAL IMPLANTATIONS OF ZIP 51(TM) MIS INTERSPINOUS IMPLANT PERFORMED

CARLSBAD, Calif., Apr 28, 2015 (GLOBE NEWSWIRE via COMTEX) — Aurora Spine Corporation (ASG) announced today the first surgical implantations of the company’s ZIP 51(TM) Minimally Invasive Interspinous Implant in the United States and Germany. The U.S. surgery was performed

© 2024 MedDeviceJobs.com Powered by Careerleaf
v.4.3-68-g7ed64c2